Save the date next month and RP

Posted:
26
August 2010

Save the date next month and RPL will see you for the American College of Clinical Pharmacologys (ACCP) 39th Annual Meeting taking place 12th to 14th September 2010 in Baltimore, Maryland.

The Annual Meeting will cover a wide array of topics such as international drug development and collaboration, pharmacometrics, pharmacogenomics, and specific sessions relating to biologics, nutraceuticals, and drug therapy in special populations, providing an ideal platform for scientists of various disciplines to meet and discuss areas of common interest.

We invite you to come down and see us at our booth that will be located in Harborside DE zone at the Baltimore Marriott Waterfront Hotel. In addition we are pleased to announce that Dr Jorg Taubel, MD., FFPM., Clinical Pharmacologist and Principal Investigator at Richmond Pharmacology, is due to present at the Annual Meeting where he will address two core topics of discussion, namely:

  • 132 - Repeated Dosing of Strontium Ranelate 4G Over 15 days Does Not Prolong QTC Interval in Healthy Volunteers
  • 133 - PET500 A Newly Formulated Tetracaine Product is Effective in Reducing Penile Sensitivity  

Dr Taubel�s presentation has been scheduled for Poster Session 2 on Monday, 13th September, 2010 from 6 PM � 7:30 PM and there are also a number of other learning activities in store, so be sure not to miss out on what is expected to be both an educational and rewarding conference.

For more information on the Annual Meeting click here for further details or click here to view the preliminary meeting program.

We look forward to seeing you next month in Baltimore!

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more